LivaNova PLC (LIVN) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Apr-24-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Neuromodulation	477.0	456.2	354.4	424.5	423.0	375.0		291.6
Other	5.2	40.8	90.7	123.0	2.1	1.8
Other	539.6	538.4	489.1	536.6	681.8	635.5
Total revenues	1,021.8	1,035.4	934.2	1,084.2	1,107.0	1,012.3	906.9	291.6
Revenue growth [+]	-1.3%	10.8%	-13.8%	-2.1%	9.4%	11.6%
Neuromodulation	4.6%	28.7%	-16.5%	0.4%	12.8%
Other	-87.2%	-55.1%	-26.2%	5630.8%	20.3%
Cost of goods sold	314.6	329.4	339.5	360.4	361.3	376.0	367.8	27.3
Gross profit	707.2	706.0	594.8	723.8	745.6	636.3	539.1	264.2
Gross margin	69.2%	68.2%	63.7%	66.8%	67.4%	62.9%	59.4%	90.6%
Selling, general and administrative	469.2	471.9	446.6	528.5	465.0	380.1	355.2	123.6
Research and development	155.8	183.4	152.9	146.8	145.9	109.5	82.1	42.2
Equity in earnings	-0.1	-0.1	-0.3		-0.6	-16.7	18.7
Other operating expenses	29.5	51.5	67.8	-107.4	366.3	33.1	31.0	9.7
EBITDA [+]	100.2	50.1	-5.4	226.6	-162.3	179.8	174.9	95.5
EBITDA growth	99.8%	-1029.7%	-102.4%	-239.6%	-190.3%	2.8%
EBITDA margin	9.8%	4.8%	-0.6%	20.9%	-14.7%	17.8%	19.3%	32.7%
Depreciation	47.6	51.1	67.3	70.7	32.7	37.1	39.9	5.8
EBITA	52.6	-0.9	-72.7	155.9	-195.0	142.7	135.0	89.7
EBITA margin	5.1%	-0.1%	-7.8%	14.4%	-17.6%	14.1%	14.9%	30.8%
Amortization of intangibles					37.2	45.9	45.5	1.0
EBIT [+]	52.6	-0.9	-72.7	155.9	-232.2	96.8	89.5	88.7
EBIT growth	-5742.8%	-98.7%	-146.7%	-167.1%	-339.9%	8.2%
EBIT margin	5.1%	-0.1%	-7.8%	14.4%	-21.0%	9.6%	9.9%	30.4%
Non-recurring items [+]	129.4		201.4	327.5	16.5	17.1	37.4
Asset impairment	129.4		201.4	327.5	0.6
Restructuring charges					15.9	17.1	37.4
Interest expense, net [+]	48.3	50.2	40.8	14.3	9.0	6.5	8.9	-0.2
Interest expense	48.3	50.2	40.8	15.1	9.8	7.8	10.6	0.0
Interest income				0.8	0.8	1.3	1.7	0.2
Other income (expense), net [+]	49.9	-73.4	-33.0	-2.5	10.2	47.8	-17.5	0.5
Acquisition-related costs					24.4	15.5	20.4	8.7
Impairment of investments						-8.6
Extraordinary gain					11.5	39.4
Other	-0.7	-0.8	2.8	2.0
Pre-tax income	-75.1	-124.5	-348.0	-188.4	-247.4	121.1	25.7	89.3
Income taxes	11.1	11.2	-1.0	-30.4	-69.6	50.0	5.1	31.4
Tax rate			0.3%	16.1%	28.1%	41.2%	19.9%	35.2%
Earnings from continuing ops	-86.2	-135.8	-347.3	-158.0	-178.5	54.5	1.9	57.8
Earnings from discontinued ops						-78.3
Net income	-86.2	-135.8	-348.8	-157.6	-189.4	-25.1	-62.8	57.8
Net margin	-8.4%	-13.1%	-37.3%	-14.5%	-17.1%	-2.5%	-6.9%	19.8%

Basic EPS [+]	($1.61)	($2.68)	($7.15)	($3.27)	($3.68)	$1.13	$0.04	$2.19
Growth	-39.9%	-62.5%	118.7%	-11.2%	-425.4%	2848.8%
Diluted EPS [+]	($1.61)	($2.68)	($7.15)	($3.27)	($3.68)	$1.12	$0.04	$2.17
Growth	-39.9%	-62.5%	118.7%	-11.2%	-427.7%	2837.1%

Shares outstanding (basic) [+]	53.5	50.6	48.6	48.3	48.5	48.2	48.9	26.4
Growth	5.6%	4.2%	0.5%	-0.3%	0.7%	-1.4%
Shares outstanding (diluted) [+]	53.5	50.6	48.6	48.3	48.5	48.5	49.0	26.6
Growth	5.6%	4.2%	0.5%	-0.3%	0.0%	-1.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.